Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Juni 2020

Planlagt Fastgjort Låst Flyttet Genmab
2.0k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • AH2005A Offline
    AH2005A Offline
    AH2005
    wrote on sidst redigeret af
    #1812

    E L@ Hva' er nu dét, E L? Er du slået over i dansk? 😄

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #1813

      😉

      1 Reply Last reply
      0
      • Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktør
        wrote on sidst redigeret af
        #1814

        😄

        1 Reply Last reply
        0
        • Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktør
          wrote on sidst redigeret af
          #1815

          Thanks again E L: https://www.proinvestor.com/index.php?p=debat_1&postid=84861

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #1816

            BioNTech to Raise USD 250 Million in Private Placement https://www.globenewswire.com/news-release/2020/06/29/2054450/0/en/BioNTech-to-Raise-USD-250-Million-in-Private-Placement.html

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #1817

              there was some discussion here if BioNTech could finance the PD-L1x4-1BB trials, this could help

              1 Reply Last reply
              0
              • Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktør
                wrote on sidst redigeret af
                #1818

                Certainly.

                1 Reply Last reply
                0
                • S Offline
                  S Offline
                  Sukkeralf
                  wrote on sidst redigeret af
                  #1819

                  Hope to hear whats next from the GEnmab/BioNTech collaboration.....maybe at the CMD in november

                  1 Reply Last reply
                  0
                  • G Offline
                    G Offline
                    GeorgeBest
                    wrote on sidst redigeret af
                    #1820

                    That is a very good investor BionTech got there!

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #1821

                      could it also be something for ESMO or SITC?

                      1 Reply Last reply
                      0
                      • S Offline
                        S Offline
                        Sukkeralf
                        wrote on sidst redigeret af
                        #1822

                        Yes the PD-L1/4-1BB could be on those - but I was thinking about the next targets

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #1823

                          ah, ok. the current products are already too many for me to keep a handle on lol . I wonder how many projects Genmab can balance at the same time with all the new staff...

                          1 Reply Last reply
                          0
                          • S Offline
                            S Offline
                            Sukkeralf
                            wrote on sidst redigeret af
                            #1824

                            Yes that could be a problem - but hopefully they will be good at killing projects also.

                            1 Reply Last reply
                            0
                            • R Offline
                              R Offline
                              Raun
                              wrote on sidst redigeret af
                              #1825

                              Link Preview Image
                              8 C25-aktier over 50% på Styrkebarometer. Genmab i top: 59%

                              Genmab 59 Chr. Hansen Holding 57 DSV 56 Novozymes B 52 Royal UNIBREW 51 Pandora 51 Novo Nordisk B 51 Bavarian Nordic 51 Ørsted 50 H. Lundbeck 50

                              favicon

                              Økonomisk Ugebrev (ugebrev.dk)

                              1 Reply Last reply
                              0
                              • BulderB Offline
                                BulderB Offline
                                Bulder
                                wrote on sidst redigeret af
                                #1826

                                Jeg vil igen opfordre til at man ikke bare linker, men skriver en bemærkning om, hvad linket omhandler. Så man ikke skal spilde tid på at følge et link, som man har set eller som ikke interesserer en.

                                1 Reply Last reply
                                0
                                • R Offline
                                  R Offline
                                  Raun
                                  wrote on sidst redigeret af
                                  #1827

                                  Ja forståeligt nok.... Har ikke lige set det tidligere, men er noteret nu 😉

                                  1 Reply Last reply
                                  0
                                  • R Offline
                                    R Offline
                                    Raun
                                    wrote on sidst redigeret af
                                    #1828

                                    Hvordan ser i på Genmab casen, som den ser ud d.d?...... Vi kan vel alle blive enige om at aktien er MEGET dyr på nøgletal. Men hvad er det egentlig der har gjort aktien så dyr?.... Der er vel 3 muligheder, som jeg ser det.... 1. Er det hedgefonde som handler den op?.... 2. Er det de institutionelle investorer som flytter deres penge fra obligationerne over i aktier, og hvad de ser som "sikre havne"... 3. Eller er det simpelthen bare en meget stor forventning til fremtiden?

                                    1 Reply Last reply
                                    0
                                    • G Offline
                                      G Offline
                                      GeorgeBest
                                      wrote on sidst redigeret af
                                      #1829

                                      Dyr? Estimeret PE for 2020 = 28

                                      1 Reply Last reply
                                      0
                                      • G Offline
                                        G Offline
                                        GeorgeBest
                                        wrote on sidst redigeret af
                                        #1830

                                        Men derudover der er tårnhøje forventninger til fremtiden...

                                        1 Reply Last reply
                                        0
                                        • Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktør
                                          wrote on sidst redigeret af
                                          #1831

                                          Deutsche Bank Corporate Bank
                                          @DBCorporateBank
                                          ·Buoyed by the success of its blockbuster anticancer drug, read this flow article featuring @Genmab
                                          's CFO Anthony Pagano on how the Danish firm’s US capital raising fits that strategy https://cib.db.com/insights-and-initiatives
                                          /flow/trust-and-agency/antibody-builders.htm

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger